Rare diseases
Investigational molecules
Locations
Study on Adding Capecitabine to Carboplatin-Based Chemotherapy for Patients with Early Triple Negative Breast Cancer
DenmarkStudy Comparing Chemotherapy Alone to Chemotherapy with Nivolumab or Nivolumab and BMS-986205 for Patients with Muscle-Invasive Bladder Cancer
AustriaStudy on Long-Term Safety and Tolerability of Iptacopan for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
CzechiaStudy on Tiotropium for Preventing Severe Asthma Attacks in Preschool Children with Uncontrolled Asthma
GermanyStudy on Guselkumab for Patients with Moderate-to-Severe Plaque Psoriasis
GermanyStudy of Durvalumab with Gemcitabine and Cisplatin for Patients with Advanced Biliary Tract Cancer
BulgariaStudy on Reducing Hormone Therapy Duration with Exemestane, Letrozole, and Anastrozole in Post-Menopausal Women with Low-Risk Hormone-Sensitive Breast Cancer
FranceStudy on the Safety and Effects of Volrustomig and Axitinib for Patients with Advanced Kidney Cancer
FranceStudy of BMS-986012, carboplatin, etoposide and nivolumab combination as first treatment for patients with extensive-stage small cell lung cancer
BelgiumStudy on Adjustable Brodalumab Dosage for Patients with Moderate-to-Severe Plaque Psoriasis Weighing 120 kg or More
BelgiumStudy of Durvalumab, Tremelimumab, and Bevacizumab for Patients with Non-Resectable Liver Cancer
GermanyStudy on the Safety of DNL310 for Children with Hunter Syndrome
The NetherlandsTell us about your condition – we search every trial in Europe and connect you with the right site.
